Neville Rodie & Shaw Inc Danaher Corp Transaction History

Neville Rodie & Shaw Inc

  • $1.36 Billion
  • Q3 2024

A detailed history of Neville Rodie & Shaw Inc transactions in Danaher Corp stock. As of the latest transaction made, Neville Rodie & Shaw Inc holds 88,753 shares of DHR stock, worth $20.5 Million. This represents 1.82% of its overall portfolio holdings.

Number of Shares
88,753
Previous 90,714 2.16%
Holding current value
$20.5 Million
Previous $22.7 Million 8.87%
% of portfolio
1.82%
Previous 1.72%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 01, 2024
SELL
$239.25 - $280.76 $469,169 - $550,570
-1,961 Reduced 2.16%
88,753 $24.7 Million
Q2 2024

Jul 01, 2024
SELL
$235.51 - $267.98 $566,637 - $644,759
-2,406 Reduced 2.58%
90,714 $22.7 Million
Q1 2024

Apr 09, 2024
BUY
$224.58 - $256.19 $508,224 - $579,757
2,263 Added 2.49%
93,120 $23.3 Million
Q4 2023

Jan 02, 2024
SELL
$185.1 - $233.13 $251,365 - $316,590
-1,358 Reduced 1.47%
90,857 $21 Million
Q3 2023

Oct 10, 2023
BUY
$233.08 - $265.59 $32,631 - $37,182
140 Added 0.15%
92,215 $22.9 Million
Q2 2023

Jul 06, 2023
BUY
$224.99 - $256.14 $775,090 - $882,402
3,445 Added 3.89%
92,075 $22.1 Million
Q1 2023

Apr 04, 2023
SELL
$239.75 - $277.0 $16,542 - $19,113
-69 Reduced 0.08%
88,630 $22.3 Million
Q4 2022

Jan 03, 2023
SELL
$241.42 - $282.29 $402,929 - $471,142
-1,669 Reduced 1.85%
88,699 $23.5 Million
Q3 2022

Oct 04, 2022
SELL
$247.06 - $1507.4 $82,765 - $504,979
-335 Reduced 0.37%
90,368 $23.3 Million
Q2 2022

Jul 06, 2022
SELL
$237.11 - $299.66 $97,215 - $122,860
-410 Reduced 0.45%
90,703 $23 Million
Q1 2022

Apr 05, 2022
SELL
$257.27 - $315.76 $283,768 - $348,283
-1,103 Reduced 1.2%
91,113 $26.6 Million
Q4 2021

Jan 05, 2022
SELL
$292.08 - $329.01 $19,277 - $21,714
-66 Reduced 0.07%
92,216 $30.3 Million
Q3 2021

Oct 06, 2021
SELL
$272.21 - $332.43 $165,503 - $202,117
-608 Reduced 0.65%
92,282 $28.1 Million
Q2 2021

Jul 06, 2021
SELL
$225.08 - $271.69 $573,954 - $692,809
-2,550 Reduced 2.67%
92,890 $24.9 Million
Q1 2021

Apr 08, 2021
SELL
$212.38 - $245.9 $420,087 - $486,390
-1,978 Reduced 2.03%
95,440 $21.5 Million
Q4 2020

Mar 04, 2021
SELL
$212.5 - $245.46 $1.31 Million - $1.51 Million
-6,170 Reduced 5.96%
97,418 $21.6 Million
Q3 2020

Oct 01, 2020
BUY
$177.16 - $215.33 $162,101 - $197,026
915 Added 0.89%
103,588 $22.3 Million
Q2 2020

Jul 15, 2020
BUY
$128.7 - $176.83 $15,830 - $21,750
123 Added 0.12%
102,673 $18.2 Million
Q1 2020

Apr 01, 2020
SELL
$121.39 - $169.05 $59,966 - $83,510
-494 Reduced 0.48%
102,550 $14.2 Million
Q4 2019

Jan 08, 2020
BUY
$133.47 - $153.48 $656,805 - $755,275
4,921 Added 5.02%
103,044 $15.8 Million
Q3 2019

Oct 02, 2019
BUY
$135.4 - $146.47 $83,271 - $90,079
615 Added 0.63%
98,123 $14.2 Million
Q2 2019

Jul 01, 2019
SELL
$124.88 - $143.73 $261,124 - $300,539
-2,091 Reduced 2.1%
97,508 $13.9 Million
Q1 2019

Apr 08, 2019
BUY
$97.62 - $132.29 $283,000 - $383,508
2,899 Added 3.0%
99,599 $13.1 Million
Q4 2018

Jan 03, 2019
BUY
$94.85 - $109.54 $172,627 - $199,362
1,820 Added 1.92%
96,700 $9.97 Million
Q3 2018

Oct 09, 2018
BUY
$98.13 - $108.9 $4.08 Million - $4.52 Million
41,548 Added 77.9%
94,880 $10.3 Million
Q2 2018

Jul 03, 2018
BUY
$96.1 - $103.24 $186,434 - $200,285
1,940 Added 3.77%
53,332 $5.26 Million
Q1 2018

Apr 12, 2018
SELL
$92.16 - $103.8 $15,667 - $17,646
-170 Reduced 0.33%
51,392 $5.03 Million
Q4 2017

Jan 03, 2018
BUY
$85.26 - $94.62 $55,419 - $61,503
650 Added 1.28%
51,562 $4.79 Million
Q3 2017

Oct 03, 2017
BUY
$79.29 - $88.45 $4.04 Million - $4.5 Million
50,912
50,912 $4.37 Million

Others Institutions Holding DHR

# of Institutions
2,511
Shares Held
540M
Call Options Held
7.07M
Put Options Held
4.55M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $168B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Neville Rodie & Shaw Inc Portfolio

Follow Neville Rodie & Shaw Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neville Rodie & Shaw Inc, based on Form 13F filings with the SEC.

News

Stay updated on Neville Rodie & Shaw Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email